Skip to content

Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations

Influence of Flat-knitted Compression Stockings Class I and II on the Morphology of Venous Malformations - Is There a Therapeutic Effect?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04637997
Enrollment
18
Registered
2020-11-20
Start date
2017-10-01
Completion date
2020-10-01
Last updated
2021-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Diseases, Vascular Malformation Peripheral, Vascular Malformations, Venous Malformation

Keywords

Compression therapy, Compression stockings class I, Compression stockings class II, Short-Form 12 (SF-12), Quality of life, Wearing comfort, Magnetic Resonance Imaging, MRI, Perometre

Brief summary

Diseases with vascular malformations are rare and often congenital, affecting patients of all ages. Depending on their extent and localization, they can cause discomfort and, especially if activity is restricted, lead to loss or reduced quality of life. The therapy is usually reserved for a few specialized centers and includes interventional sclerotherapy as well as conservative therapy by compression with appropriate compression stockings. However, there are currently no study-based recommendations for this approach. The aim of this study is to prove a therapeutic effect of compression therapy using flat-knitted compression stockings on venous malformations of the extremities and to derive from this a therapy recommendation in connection with an improvement in the health status and quality of life. For this purpose, patients with a confirmed venous malformation of the upper or lower extremity independent of previous therapy will be included. We will investigate patients with epi- and/or subfascial localization of the venous malformation independent of the local extent (cross-articular or not).

Interventions

DEVICEcompression stockings class I

Daily wearing of compression stockings class I for four weeks on the affected extremity.

DEVICEcompression stockings class II

Daily wearing of compression stockings class II for four weeks on the affected extremity.

Sponsors

University Hospital Erlangen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Double-blind study. Neither investigator nor patient knows the compression class (class I versus class II) of the compression stockings used in the different investigation periods in this patient.

Intervention model description

This is a single group study with crossover components. Participants receive randomly and double-blinded either class I compression stockings or class II compression stockings. After four weeks, an exchange of compression classes takes place, so that all participants wear both classes of compression stockings within eight weeks.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with a confirmed venous malformation of the upper/lower extremity independent of previous therapy with epi- and/or subfascial localization of the venous malformation independent of the local extent (cross-articular or not) * Compression stocking can be put on independently or by the parents * Written declaration of consent present

Exclusion criteria

* Lack of compliance, patient is not available for control appointments * Additional drug therapy (anticoagulation) for extensive venous malformations with threatening thromboembolic complications * Known allergic reaction/intolerance to components of flat-knitted compression stockings * Pregnancy * Rejection of the study participation by the patient * Contraindications for the planned MRI examination (pacemakers, implants not suitable for MRI, claustrophobia) * Occurrence of an emergency situation * Severe heart failure as contraindication for compression therapy * Peripheral arterial disease as contraindication for compression therapy

Design outcomes

Primary

MeasureTime frameDescription
Volume Difference of Malformation to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by MRIone dayDetermination and comparison of volume difference of the malformation after application of compression stockings class I and II compared to baseline (no compression) measured non-invasively by MRI.
Volume Difference of the Affected Extremity to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by Perometreone dayDetermination and comparison of volume difference of the affected extremity after application of compression stockings class I and II compared to baseline (no compression) measured non-invasively by perometre.

Secondary

MeasureTime frameDescription
Difference Between Quality of Life at Baseline (no Compression at Day 28) and Compression Classes I and II by Short Form-12 (SF-12) Health Survey at Day 56 or 84up to two monthsSF-12v2 (SOEP-Version 2004) scale is a generic, multipurpose short-form survey with 12 questions selected from the SF-36 Health Survey which, when combined, scored and weighted, results in two scales of mental (MCS) and physical (PCS) functioning and overall health-related quality of life. A higher value indicates a better quality of life of the patient. The scores range from 0 to 100. The overall mean for each scale is 50 points and the standard deviation is 10 points in the SOEP sample.

Countries

Germany

Participant flow

Recruitment details

Participants were informed about the possibility of participating in the study during a routine presentation of the vascular surgery consultation Hours during 01.10.2017-01.12.2018.

Participants by arm

ArmCount
Study Group 1
Wearing of compression stockings class I between Investigation day 28 to 56. Wearing of compression stockings class II between Investigation day 56 to 84. compression stockings class I: Daily wearing of compression stockings class I for four weeks on the affected extremity. compression stockings class II: Daily wearing of compression stockings class II for four weeks on the affected extremity.
9
Study Group 2
Wearing of compression stockings class II between Investigation day 28 to 56. Wearing of compression stockings class I between Investigation day 56 to 84. compression stockings class I: Daily wearing of compression stockings class I for four weeks on the affected extremity. compression stockings class II: Daily wearing of compression stockings class II for four weeks on the affected extremity.
9
Total18

Baseline characteristics

CharacteristicTotalStudy Group 1Study Group 2
Affected part of body
arm
5 Participants4 Participants1 Participants
Affected part of body
lower limb
5 Participants3 Participants2 Participants
Affected part of body
upper and lower limb
2 Participants0 Participants2 Participants
Affected part of body
upper limb
6 Participants2 Participants4 Participants
Age, Continuous27.17 years
STANDARD_DEVIATION 24.45
26.22 years
STANDARD_DEVIATION 18.91
28.11 years
STANDARD_DEVIATION 15.5
Previous therapy8 Participants5 Participants3 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Germany
18 participants9 participants9 participants
Sex: Female, Male
Female
12 Participants6 Participants6 Participants
Sex: Female, Male
Male
6 Participants3 Participants3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 180 / 18
other
Total, other adverse events
0 / 180 / 18
serious
Total, serious adverse events
0 / 180 / 18

Outcome results

Primary

Volume Difference of Malformation to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by MRI

Determination and comparison of volume difference of the malformation after application of compression stockings class I and II compared to baseline (no compression) measured non-invasively by MRI.

Time frame: one day

Population: Intention-to-treat population (ITT): all randomized participants that received flat-knitted compression stockings class I and class II after the randomization.

ArmMeasureValue (MEAN)Dispersion
Compression Stockings Class IVolume Difference of Malformation to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by MRI16.38 mlStandard Deviation 18.28
Compression Stockings Class IIVolume Difference of Malformation to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by MRI23.7 mlStandard Deviation 25.67
Primary

Volume Difference of the Affected Extremity to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by Perometre

Determination and comparison of volume difference of the affected extremity after application of compression stockings class I and II compared to baseline (no compression) measured non-invasively by perometre.

Time frame: one day

Population: Intention-to-treat population (ITT): all randomized participants that received flat-knitted compression stockings class I and class II after the randomization.

ArmMeasureValue (MEAN)Dispersion
Compression Stockings Class IVolume Difference of the Affected Extremity to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by Perometre124 mlStandard Deviation 351.09
Compression Stockings Class IIVolume Difference of the Affected Extremity to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by Perometre90.22 mlStandard Deviation 226.7
Secondary

Difference Between Quality of Life at Baseline (no Compression at Day 28) and Compression Classes I and II by Short Form-12 (SF-12) Health Survey at Day 56 or 84

SF-12v2 (SOEP-Version 2004) scale is a generic, multipurpose short-form survey with 12 questions selected from the SF-36 Health Survey which, when combined, scored and weighted, results in two scales of mental (MCS) and physical (PCS) functioning and overall health-related quality of life. A higher value indicates a better quality of life of the patient. The scores range from 0 to 100. The overall mean for each scale is 50 points and the standard deviation is 10 points in the SOEP sample.

Time frame: up to two months

Population: Intention-to-treat population (ITT): all randomized participants that received flat-knitted compression stockings class I and class II after the randomization.

ArmMeasureGroupValue (MEAN)Dispersion
Compression Stockings Class IDifference Between Quality of Life at Baseline (no Compression at Day 28) and Compression Classes I and II by Short Form-12 (SF-12) Health Survey at Day 56 or 84PCS1.9505 units on a scaleStandard Deviation 7.2323
Compression Stockings Class IDifference Between Quality of Life at Baseline (no Compression at Day 28) and Compression Classes I and II by Short Form-12 (SF-12) Health Survey at Day 56 or 84MCS1.0922 units on a scaleStandard Deviation 9.6244
Compression Stockings Class IDifference Between Quality of Life at Baseline (no Compression at Day 28) and Compression Classes I and II by Short Form-12 (SF-12) Health Survey at Day 56 or 84Overall Health-related Quality of life1.5214 units on a scaleStandard Deviation 4.24
Compression Stockings Class IIDifference Between Quality of Life at Baseline (no Compression at Day 28) and Compression Classes I and II by Short Form-12 (SF-12) Health Survey at Day 56 or 84PCS3.3461 units on a scaleStandard Deviation 7.321
Compression Stockings Class IIDifference Between Quality of Life at Baseline (no Compression at Day 28) and Compression Classes I and II by Short Form-12 (SF-12) Health Survey at Day 56 or 84MCS0.1778 units on a scaleStandard Deviation 6.865
Compression Stockings Class IIDifference Between Quality of Life at Baseline (no Compression at Day 28) and Compression Classes I and II by Short Form-12 (SF-12) Health Survey at Day 56 or 84Overall Health-related Quality of life1.762 units on a scaleStandard Deviation 3.164

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026